406 related articles for article (PubMed ID: 8290343)
1. Instability of the monofunctional adducts in cis-[Pt(NH3)2(N7-N-methyl-2-diazapyrenium)Cl](2+)-modified DNA: rates of cross-linking reactions in cis-platinum-modified DNA.
Payet D; Gaucheron F; Sip M; Leng M
Nucleic Acids Res; 1993 Dec; 21(25):5846-51. PubMed ID: 8290343
[TBL] [Abstract][Full Text] [Related]
2. Rearrangement of interstrand cross-links into intrastrand cross-links in cis-diamminedichloroplatinum(II)-modified DNA.
Pérez C; Leng M; Malinge JM
Nucleic Acids Res; 1997 Feb; 25(4):896-903. PubMed ID: 9016644
[TBL] [Abstract][Full Text] [Related]
3. Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure.
Hegmans A; Berners-Price SJ; Davies MS; Thomas DS; Humphreys AS; Farrell N
J Am Chem Soc; 2004 Feb; 126(7):2166-80. PubMed ID: 14971952
[TBL] [Abstract][Full Text] [Related]
4. Formation of a DNA monofunctional cis-platinum adduct cross-linking the intercalating drug N-methyl-2,7-diazapyrenium.
Malinge JM; Sip M; Blacker AJ; Lehn JM; Leng M
Nucleic Acids Res; 1990 Jul; 18(13):3887-91. PubMed ID: 2374713
[TBL] [Abstract][Full Text] [Related]
5. Lability of monofunctional cis-platinum adducts: role of DNA double helix.
Anin MF; Gaucheron F; Leng M
Nucleic Acids Res; 1992 Sep; 20(18):4825-30. PubMed ID: 1408797
[TBL] [Abstract][Full Text] [Related]
6. Possible catalytic activity of DNA in the reaction between the antitumor drug cis-diamminedichloroplatinum(II) and the intercalator N-methyl-2,7-diazapyrenium.
Gaucheron F; Malinge JM; Blacker AJ; Lehn JM; Leng M
Proc Natl Acad Sci U S A; 1991 May; 88(9):3516-9. PubMed ID: 2023897
[TBL] [Abstract][Full Text] [Related]
7. Bending studies of DNA site-specifically modified by cisplatin, trans-diamminedichloroplatinum(II) and cis-[Pt(NH3)2(N3-cytosine)Cl]+.
Bellon SF; Lippard SJ
Biophys Chem; 1990 Apr; 35(2-3):179-88. PubMed ID: 2397272
[TBL] [Abstract][Full Text] [Related]
8. Replication inhibition and translesion synthesis on templates containing site-specifically placed cis-diamminedichloroplatinum(II) DNA adducts.
Comess KM; Burstyn JN; Essigmann JM; Lippard SJ
Biochemistry; 1992 Apr; 31(16):3975-90. PubMed ID: 1314653
[TBL] [Abstract][Full Text] [Related]
9. Base sequence-independent distorsions induced by interstrand cross-links in cis-diamminedichloroplatinum (II)-modified DNA.
Malinge JM; Pérez C; Leng M
Nucleic Acids Res; 1994 Sep; 22(19):3834-9. PubMed ID: 7937101
[TBL] [Abstract][Full Text] [Related]
10. Linkage isomerization reaction of intrastrand cross-links in trans-diamminedichloroplatinum(II)-modified single-stranded oligonucleotides.
Dalbiès R; Boudvillain M; Leng M
Nucleic Acids Res; 1995 Mar; 23(6):949-53. PubMed ID: 7731808
[TBL] [Abstract][Full Text] [Related]
11. DNA interactions of a novel platinum drug, cis-[PtCl(NH3)2(N7-acyclovir)]+.
Balcarová Z; Kaspárková J; Zákovská A; Nováková O; Sivo MF; Natile G; Brabec V
Mol Pharmacol; 1998 May; 53(5):846-55. PubMed ID: 9584210
[TBL] [Abstract][Full Text] [Related]
12. Intrastrand cross-links are not formed in the reaction between transplatin and native DNA: relation with the clinical inefficiency of transplatin.
Boudvillain M; Dalbiès R; Aussourd C; Leng M
Nucleic Acids Res; 1995 Jul; 23(13):2381-8. PubMed ID: 7630715
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents.
Hollis LS; Sundquist WI; Burstyn JN; Heiger-Bernays WJ; Bellon SF; Ahmed KJ; Amundsen AR; Stern EW; Lippard SJ
Cancer Res; 1991 Apr; 51(7):1866-75. PubMed ID: 2004370
[TBL] [Abstract][Full Text] [Related]
14. Chemical versatility of transplatin monofunctional adducts within multiple site-specifically platinated DNA.
Bernal-Méndez E; Boudvillain M; González-Vilchez F; Leng M
Biochemistry; 1997 Jun; 36(24):7281-7. PubMed ID: 9200676
[TBL] [Abstract][Full Text] [Related]
15. DNA interactions of antitumor trans-[PtCl2(NH3)(quinoline)].
Zákovská A; Nováková O; Balcarová Z; Bierbach U; Farrell N; Brabec V
Eur J Biochem; 1998 Jun; 254(3):547-57. PubMed ID: 9688265
[TBL] [Abstract][Full Text] [Related]
16. The quantitative detection of various Pt-DNA-adducts in Chinese hamster ovary cells treated with cisplatin: application of immunochemical techniques.
Plooy AC; Fichtinger-Schepman AM; Schutte HH; van Dijk M; Lohman PH
Carcinogenesis; 1985 Apr; 6(4):561-6. PubMed ID: 4039227
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin.
Donahue BA; Augot M; Bellon SF; Treiber DK; Toney JH; Lippard SJ; Essigmann JM
Biochemistry; 1990 Jun; 29(24):5872-80. PubMed ID: 2383564
[TBL] [Abstract][Full Text] [Related]
18. Cooperative effects in long-range 1,4 DNA-DNA interstrand cross-links formed by polynuclear platinum complexes: an unexpected syn orientation of adenine bases outside the binding sites.
Qu Y; Scarsdale NJ; Tran MC; Farrell NP
J Biol Inorg Chem; 2003 Jan; 8(1-2):19-28. PubMed ID: 12459895
[TBL] [Abstract][Full Text] [Related]
19. DNA-DNA interstrand cross-linking by cis-diamminedichloroplatinum(II): N7(dG)-to-N7(dG) cross-linking at 5'-d(GC) in synthetic oligonucleotides.
Huang H; Woo J; Alley SC; Hopkins PB
Bioorg Med Chem; 1995 Jun; 3(6):659-69. PubMed ID: 7582944
[TBL] [Abstract][Full Text] [Related]
20. Monofunctional platinum amine complexes destabilize DNA significantly.
Bauer C; Peleg-Shulman T; Gibson D; Wang AH
Eur J Biochem; 1998 Sep; 256(2):253-60. PubMed ID: 9760162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
